The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of circulating cytokines as markers of docetaxel (DTX) resistance in metastatic castrate-resistant prostate cancer (mCRPC).
 
Kate Lynette Mahon
No Relationships to Disclose
 
Hui-Ming Lin
No Relationships to Disclose
 
Calan Spielman
No Relationships to Disclose
 
Michelle Lee-Ng
No Relationships to Disclose
 
Howard Gurney
No Relationships to Disclose
 
Girish Mallesara
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)
 
Karen P. Briscoe
No Relationships to Disclose
 
Gavin M. Marx
Honoraria - Sanofi
Consulting or Advisory Role - Janssen; Sanofi
 
Samuel N. Breit
Patents, Royalties, Other Intellectual Property - Patent pending on MIC1
 
David A. Brown
Patents, Royalties, Other Intellectual Property - patent pending on MIC1
 
Lisa Horvath
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Lilly; Pfizer; Roche